- Poster presentation
- Published:
Prognostic value of procalcitonin in respiratory tract infections across clinical settings
Critical Care volume 19, Article number: P65 (2015)
Introduction
Whether the inflammatory biomarker procalcitonin (PCT) provides prognostic information across clinical settings and different acute respiratory tract infections (ARI) is poorly understood. Herein, we investigated the prognostic value of admission PCT levels to predict adverse clinical outcome in a large ARI population.
Methods
We analyzed data from 14 trials and 4,211 ARI patients to study associations of admission PCT levels and setting specific treatment failure and mortality alone at 30 days. We used multivariable hierarchical logistic regression and conducted sensitivity analyses stratified by clinical settings and ARI diagnoses to assess the results' consistency.
Results
Overall, 864 patients (20.5%) experienced treatment failure and 252 (6.0%) died. The ability of PCT to differentiate patients with and without treatment failure was highest in the emergency department setting (treatment failure; area under the curve (AUC): 0.64 (95% confidence interval (CI): 0.61, 0.67), adjusted odds ratio (OR): 1.85 (95% CI: 1.61, 2.12), P < 0.001 - mortality; AUC: 0.67 (95% CI: 0.63, 0.71), adjusted OR: 1.82 (95% CI: 1.45, 2.29), P < 0.001). In lower respiratory tract infections, PCT was a good predictor of identifying patients at risk for mortality (AUC: 0.71 (95% CI: 0.68, 0.74), adjusted OR: 2.13 (95% CI: 1.82, 2.49), P < 0.001). In primary care and ICU patients no significant associations of initial PCT levels and outcome were found. See Figure 1.
Conclusion
Admission PCT levels are associated with setting specific treatment failure and provide most prognostic information in ARI in the emergency department setting.
References
Schuetz P, Briel M, Christ-Crain M, et al: Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis. 2012, 55: 651-62. 10.1093/cid/cis464.
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Kutz, A., Mueller, B., Schuetz, P. et al. Prognostic value of procalcitonin in respiratory tract infections across clinical settings. Crit Care 19 (Suppl 1), P65 (2015). https://doi.org/10.1186/cc14145
Published:
DOI: https://doi.org/10.1186/cc14145